CN104189759A - Traditional Chinese medicine composition for treating cholelithiasis - Google Patents
Traditional Chinese medicine composition for treating cholelithiasis Download PDFInfo
- Publication number
- CN104189759A CN104189759A CN201410462424.XA CN201410462424A CN104189759A CN 104189759 A CN104189759 A CN 104189759A CN 201410462424 A CN201410462424 A CN 201410462424A CN 104189759 A CN104189759 A CN 104189759A
- Authority
- CN
- China
- Prior art keywords
- parts
- traditional chinese
- chinese medicine
- medicine composition
- radix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Abstract
The invention relates to a traditional Chinese medicine composition for treating cholelithiasis through oral administration, and belongs to traditional Chinese medicines. The traditional Chinese medicine composition is characterized by being prepared from the following traditional Chinese medicines in parts by weight: 30 parts of lysimachia christinae hance, 12 parts of lygodium japonicum, 10 parts of endothelium corneum gigeriae galli, 6 parts of abliflora, 10 parts of radix curcumae, 15 parts of corn stigmas, 9 parts of radix bupleuri, 15 parts of capillary Artemisia, 9 parts of pericarpium citri reticulatae viride, 12 parts of betel nuts, 12 parts of immature bitter orange, 12 parts of mangnolia officinalis, 6 parts of rheum officinale, 9 parts of parched white peony root and 6 parts of honey-fried licorice root. The traditional Chinese medicine composition has the effects of clearing away heat and dampness, smoothen liver and Qi, benefiting gallbladder and relaxing bowel, takes a quick effect on treating cholelithiasis, and has the advantages of short treatment course and safety and convenience in oral administration.
Description
Technical field:
The present invention relates to a kind of Chinese medicine composition of orally taken for curing cholelithiasis, belong to the field of Chinese medicines.
Background technology:
Cholelithiasis refers to biliary system, comprises the disease that calculus occurs in gallbladder and bile duct.Different by calculus happening part, can be divided into cholelithiasis, extrahepatic biliary stone and calculus of intrahepatic duct.The origin cause of formation of cholelithiasis is very complicated, not yet has clear and definite conclusion at present.It is generally acknowledged the change of the physical chemical factor of bile, the alluvial of bile, and the infection of biliary system is the principal element of morbidity.In China, along with the aging of population, the change of dietary structure, its sickness rate is the trend rising year by year.
Chinese medicine is thought due to disorder of emotion, eating and drinking without temperance, causes damp-heat accumulation in liver and gall, and the bright bile of heat, forms stone for a long time, sends out as cholelithiasis.Clinically with removing damp-heat, depressed liver-energy dispersing and QI regulating, function of gallbladder promoting purging FU-organs is principle for the treatment of, has obtained good therapeutic effect.
Summary of the invention:
Technical problem to be solved by this invention is to provide a kind of Chinese medicine composition of orally taken for curing cholelithiasis.
The present invention is achieved by the following technical solutions.A Chinese medicine composition for orally taken for curing cholelithiasis, is characterized in that being made by the raw material of Chinese medicine of following parts by weight:
Herba Lysimachiae 30, Spora Lygodii 12, Endothelium Corneum Gigeriae Galli 10, FLOS MUME 6, Radix Curcumae 10, Stigma Maydis 15, Radix Bupleuri 9, Herba Artemisiae Scopariae 15, Pericarpium Citri Reticulatae Viride 9, Semen Arecae 12, Fructus Aurantii Immaturus 12, Cortex Magnoliae Officinalis 12, Radix Et Rhizoma Rhei 6, Radix Paeoniae Alba (parched) 9, Radix Glycyrrhizae Preparata 6.
Single dose dose (unit: gram): Herba Lysimachiae 30, Spora Lygodii 12, Endothelium Corneum Gigeriae Galli 10, FLOS MUME 6, Radix Curcumae 10, Stigma Maydis 15, Radix Bupleuri 9, Herba Artemisiae Scopariae 15, Pericarpium Citri Reticulatae Viride 9, Semen Arecae 12, Fructus Aurantii Immaturus 12, Cortex Magnoliae Officinalis 12, Radix Et Rhizoma Rhei 6, Radix Paeoniae Alba (parched) 9, Radix Glycyrrhizae Preparata 6.
Preparation and instructions of taking: be decocted in water for oral dose, every day, potion, divided twice one after each meal sooner or later, within 10 days, was a course for the treatment of.
Drug action mechanism of the present invention is as follows:
Herba Lysimachiae: slightly sweet flavor, property is flat; Return liver and gall kidney urinary bladder channel; Relieving stranguria by diuresis, dehumidifying jaundice eliminating.
Spora Lygodii: sweet in the mouth, cold in nature; Return bladder small intestine meridian; Relieving stranguria by diuresis.
Endothelium Corneum Gigeriae Galli: sweet in the mouth, property is flat; Return taste small intestinal urinary bladder channel; Activating the spleen helps digestion, and controlling nocturnal emission with astringent drugs is only lost.
FLOS MUME: sour in the mouth, property is flat; Return liver, stomach warp; Dispersing the stagnated live-QI to relieve the stagnation of QI.Regulating qi-flowing for harmonizing stomach.
Radix Curcumae: acrid in the mouth is bitter, cold nature; GUIXIN lung Liver Channel; Promoting QI circulation for relieving depression, removing heat from blood removing blood stasis with potent drugs.
Stigma Maydis: sweet in the mouth, property is flat; Return kidney liver and gall warp; Diuresis, expels the heat-evil, suppressing the hyperactive liver, function of gallbladder promoting.
Radix Bupleuri: acrid in the mouth is bitter, cold nature; Return liver and gall warp; Reconciling superficies and interior, soothing the liver, yang invigorating.
Herba Artemisiae Scopariae: bitter in the mouth, cold nature; Return taste liver and gall warp; Eliminating damp-heat, jaundice eliminating subcutaneous ulcer.
Pericarpium Citri Reticulatae Viride: acrid in the mouth is bitter, warm in nature; Return liver and gall stomach warp; Soothing the liver dispelling the stagnated QI, eliminating stagnation disappears stagnant.
Semen Arecae: acrid in the mouth is bitter, warm in nature; Return stomach large intestine channel; Parasite killing, removing food stagnancy, circulation of qi promoting, diuretic.
Fructus Aurantii Immaturus: acrid in the mouth is bitter, cold nature; Return taste large intestine channel; Dispelling the stagnated QI removing food stagnancy, reduces phlegm except painful abdominal mass.
Cortex Magnoliae Officinalis: acrid in the mouth is bitter, warm in nature; Return taste lung large intestine channel; Circulation of qi promoting, dampness, removing food stagnancy, relieving asthma.
Radix Et Rhizoma Rhei: bitter in the mouth, cold in nature; Return taste large intestine liver heart channel; Heat and toxic materials clearing away, clearing away heat-fire, removing toxic substances, blood circulation promoting and blood stasis dispelling.
Radix Paeoniae Alba (parched): sour in the mouth is bitter, cold nature; Return liver spleen channel; Nourishing blood to suppress the hyperactive liver, relieving spasm to stop pain, astringing YIN to stop sweating.
Radix Glycyrrhizae Preparata: sweet in the mouth, property is flat; GUIXIN taste lung meridian; With middle emergency, nourishing the lung to arrest cough, coordinating the actions of various ingredients in a prescription.
Below in conjunction with clinical trial and model case, the present invention is further described.
One, clinical trial
1, clinical data: choose Patients with Cholelithiasis 100 examples of 18~59 years old, wherein, male's 42 examples, women's 58 examples, course of disease varying length.
2, Therapeutic Method: treatment group is taken medicine of the present invention, oral, every day, potion, divided twice one after each meal sooner or later, within 10 days, was a course for the treatment of, took altogether 5 courses for the treatment of.
3, efficacy assessment standard:
Excellent: clinical symptoms, sign disappear, and calculus is discharged completely.
Good: under right flank portion or xiphoid-process, pain and symptom of digestive tract disappear, without obvious tenderness, imaging examination prompting calculus volume-diminished, or calculus decreased number.
Poor: symptom has no improvement, imaging examination confirms that calculus, without melting variation, even occurs the complication such as incarceration, infection, perforation.
4, therapeutic outcome: treatment group after the treatment of 50 days, excellent 38 examples, good 57 examples, differ from 5 examples, total effective rate 95%.
Two, model case:
Example one: Xu certain, man, 64 years old, over 4 years, suffer from cholelithiasis disease, frequent right flank portion distending pain, the frequent yellow skin of urine is as tea, is reluctant with age operation, comes to seek medical advice.Give Drug therapy of the present invention 20 days, patient's right flank distending pain transference cure, urine transfers to faint yellow, following the service 30 days, check B ultrasonic cholelithiasis disappears.
Example two: Lee, female, 51 years old, patient over 5 years because of cholelithiasis, choledocholithiasis, twice row operative treatment successively, before 1 year, felt again right Upper abdominal pain, the heat that occurs together, ultrasound diagnosis prompting: calculus of intrahepatic duct, patient fears operation again, give Drug therapy of the present invention 40 days, check B ultrasonic calculus disappears.
Example three: what certain, female, 51 years old, often there is paroxysmal right upper quadrant of the abdomen pain in patient over 3 years, and the shoulder back of the body diffuses to the right, row courage type-B ultrasonic showed at that time: cholecystitis, does not cause enough attention.The pain increased for right upper quadrant of the abdomen recently, and row courage type-B ultrasonic shows: cholelithiasis, give Drug therapy of the present invention 10 days, and patient's right upper quadrant of the abdomen pain symptom obviously alleviates, following the service 40 days, check B ultrasonic cholelithiasis disappears.
The present invention has the following advantages:
(1) Chinese herbal medicine used in the present invention all meets Pharmacopoeia of People's Republic of China regulation, and according to compatibility, the present invention has removing damp-heat, depressed liver-energy dispersing and QI regulating, the effect of function of gallbladder promoting purging FU-organs.
(2) the present invention not only has good therapeutical effect to cholelithiasis, and the prevention of this disease is also had to good effect.
(3) rigorous, the science of prescription of the present invention, has advantages of instant effect, short treating period, takes safe ready.
The specific embodiment:
Embodiment
Take by weight raw material:
Herba Lysimachiae 30, Spora Lygodii 12, Endothelium Corneum Gigeriae Galli 10, FLOS MUME 6, Radix Curcumae 10, Stigma Maydis 15, Radix Bupleuri 9, Herba Artemisiae Scopariae 15, Pericarpium Citri Reticulatae Viride 9, Semen Arecae 12, Fructus Aurantii Immaturus 12, Cortex Magnoliae Officinalis 12, Radix Et Rhizoma Rhei 6, Radix Paeoniae Alba (parched) 9, Radix Glycyrrhizae Preparata 6.
Preparation and instructions of taking: be decocted in water for oral dose, every day, potion, divided twice one after each meal sooner or later, within 10 days, was a course for the treatment of.
Claims (1)
1. a Chinese medicine composition for orally taken for curing cholelithiasis, is characterized in that being made by the raw material of Chinese medicine of following parts by weight: Herba Lysimachiae 30, Spora Lygodii 12, Endothelium Corneum Gigeriae Galli 10, FLOS MUME 6, Radix Curcumae 10, Stigma Maydis 15, Radix Bupleuri 9, Herba Artemisiae Scopariae 15, Pericarpium Citri Reticulatae Viride 9, Semen Arecae 12, Fructus Aurantii Immaturus 12, Cortex Magnoliae Officinalis 12, Radix Et Rhizoma Rhei 6, Radix Paeoniae Alba (parched) 9, Radix Glycyrrhizae Preparata 6.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410462424.XA CN104189759A (en) | 2014-09-03 | 2014-09-03 | Traditional Chinese medicine composition for treating cholelithiasis |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410462424.XA CN104189759A (en) | 2014-09-03 | 2014-09-03 | Traditional Chinese medicine composition for treating cholelithiasis |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104189759A true CN104189759A (en) | 2014-12-10 |
Family
ID=52075230
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410462424.XA Pending CN104189759A (en) | 2014-09-03 | 2014-09-03 | Traditional Chinese medicine composition for treating cholelithiasis |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104189759A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105012435A (en) * | 2015-07-27 | 2015-11-04 | 綦声波 | Traditional Chinese medicine composition treating yin-deficiency type postcholecystectomy syndrome |
CN105288547A (en) * | 2015-11-13 | 2016-02-03 | 庄小侃 | Traditional Chinese medicine preparation used for treating liver and gallbladder damp-heat type cholecystolithiasis |
CN105688078A (en) * | 2016-03-23 | 2016-06-22 | 欧卉 | Traditional Chinese medicine recipe for treating biliary tract disease |
CN105902845A (en) * | 2016-04-12 | 2016-08-31 | 杨见添 | Calculus eliminating drug |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1868531A (en) * | 2005-05-23 | 2006-11-29 | 宿连存 | Traditional Chinese medicine composition for treating hepatolith |
CN101695560A (en) * | 2009-10-14 | 2010-04-21 | 张家政 | Chinese medicinal composition for treating concrement |
CN103736034A (en) * | 2014-01-28 | 2014-04-23 | 王心聚 | Drug for treating cholecystitis and preparation method thereof |
-
2014
- 2014-09-03 CN CN201410462424.XA patent/CN104189759A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1868531A (en) * | 2005-05-23 | 2006-11-29 | 宿连存 | Traditional Chinese medicine composition for treating hepatolith |
CN101695560A (en) * | 2009-10-14 | 2010-04-21 | 张家政 | Chinese medicinal composition for treating concrement |
CN103736034A (en) * | 2014-01-28 | 2014-04-23 | 王心聚 | Drug for treating cholecystitis and preparation method thereof |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105012435A (en) * | 2015-07-27 | 2015-11-04 | 綦声波 | Traditional Chinese medicine composition treating yin-deficiency type postcholecystectomy syndrome |
CN105288547A (en) * | 2015-11-13 | 2016-02-03 | 庄小侃 | Traditional Chinese medicine preparation used for treating liver and gallbladder damp-heat type cholecystolithiasis |
CN105688078A (en) * | 2016-03-23 | 2016-06-22 | 欧卉 | Traditional Chinese medicine recipe for treating biliary tract disease |
CN105902845A (en) * | 2016-04-12 | 2016-08-31 | 杨见添 | Calculus eliminating drug |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102091282B (en) | Medicament for treating chronic gastritis and gastric ulcer | |
CN101693102A (en) | Traditional Chinese medicine compound for treating diseases of incoordination between the spleen and the stomach and abdominal fullness and distention and preparation method thereof | |
CN101670060A (en) | Traditional Chinese medicine composition for treating such diseases as hepatic stagnation, chest stuffiness and distension and preparation method | |
CN102772778A (en) | Chinese medicinal composition for treating summer heat-dampness | |
CN104189759A (en) | Traditional Chinese medicine composition for treating cholelithiasis | |
CN103251898B (en) | Traditional Chinese medicine preparation for treating dysmenorrhea | |
CN103933370B (en) | A kind of Chinese medicine decoction treating stagnated QI transforming into fire pattern of syndrome cranial tinnitus | |
CN103251899B (en) | Oral drug for treating dysmenorrhea | |
CN102430105A (en) | Traditional Chinese medicine composite for treating chronic gastritis | |
CN103006980B (en) | Chinese medicinal composition for treating distention and fullness | |
CN102940820B (en) | Traditional Chinese medicine composition for treating diarrhea | |
CN104771652A (en) | Vertigo treating traditional Chinese medicine composition | |
CN103830645A (en) | Oral liquid for treating halitosis | |
CN103212020A (en) | Traditional Chinese medicine composition for treating functional dyspepsia | |
CN103251901B (en) | Oral traditional Chinese medicine preparation for treating dysmenorrhea | |
CN103212013B (en) | Chinese medicinal composition for treating epigastric pain | |
CN105796891A (en) | Traditional Chinese medicinal composition for treating epigastric pain | |
CN104758652A (en) | Traditional Chinese medicine composition for treating dizziness | |
CN101653495B (en) | Chinese traditional medicine for curing insomnia | |
CN101297948B (en) | Chinese medicine lotion preparation for treating chest wall soft tissue injury | |
CN105920302A (en) | Traditional Chinese medicine composition for treating gallstone | |
CN101757545A (en) | Traditional Chinese medicine for treating cholelithasis | |
CN105169301A (en) | Traditional Chinese medicine composition treating phlegm-damp stagnation abnormal menstruation | |
CN105412561A (en) | Medicine for treating anhypnia | |
CN105079094A (en) | Traditional Chinese medicine composition for treating hemafecia |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20141210 |
|
WD01 | Invention patent application deemed withdrawn after publication |